Eton Pharmaceuticals (ETON) Total Debt (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Total Debt of $30.6 million for Q4 2025, up 0.63% sequentially from $30.4 million in Q3 2025, and up 2.51% YoY from $29.8 million in Q4 2024.
Eton Pharmaceuticals (ETON) Total Debt (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Total Debt for 7 years, with the latest figure at $30.6 million in Q4 2025.
- Quarterly Total Debt rose 2.51% year-over-year to $30.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.6 million (up 2.51% YoY) and the FY2025 annual result came in at $30.6 million, up 2.51% from the prior year.
- Total Debt improved to $30.6 million in Q4 2025 per ETON's latest filing, from $30.4 million in the prior quarter.
- Over five years, Total Debt peaked at $30.6 million in Q4 2025 and troughed at $4.1 million in Q3 2024.
- A 5-year average of $12.0 million and a median of $6.4 million in 2022 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2025: Total Debt slipped 28.1% in 2024, then soared 636.17% in 2025.
- Over 5 years, Total Debt stood at $6.7 million in 2021, then dropped by 3.94% to $6.4 million in 2022, then decreased by 16.16% to $5.4 million in 2023, then jumped by 454.11% to $29.8 million in 2024, then grew by 2.51% to $30.6 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $30.6 million, $30.4 million, and $30.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 27.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.90 Mn |
| Dec 31, 2025 | 30.56 Mn |
| Sep 30, 2025 | 30.37 Mn |
| Jun 30, 2025 | 30.18 Mn |
| Mar 31, 2025 | 29.99 Mn |
| Dec 31, 2024 | 29.81 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 5.02 Mn |
| Dec 31, 2023 | 5.38 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 6.09 Mn |
| Mar 31, 2023 | 6.45 Mn |
| Dec 31, 2022 | 6.42 Mn |
| Sep 30, 2022 | 6.39 Mn |
| Jun 30, 2022 | 6.36 Mn |
| Mar 31, 2022 | 6.33 Mn |
| Dec 31, 2021 | 6.68 Mn |
| Sep 30, 2021 | 6.64 Mn |
| Jun 30, 2021 | 6.61 Mn |